Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Eli Lilly and Company Plans Goochland County, Virginia, Specialty Pharmaceutical Operations

09/19/2025
Global pharmaceutical firm Eli Lilly and Company plans to establish manufacturing operations in Goochland County, Virginia. The $5 billion project is expected to create 650 jobs.

The investment will include the construction of the company’s first dedicated, fully integrated active pharmaceutical ingredient and drug product facility, located at the West Creek Business Park, which will focus on its bioconjugate platform and monoclonal antibody portfolio.

“Our investment in Virginia underscores our commitment to U.S. innovation and manufacturing – creating high-quality jobs, strengthening communities, and advancing the health and well-being of Americans nationwide,” said Lilly Chair and CEO David A. Ricks. “By expanding our domestic capacity, we’re building a secure, resilient supply chain that delivers for patients today and supports the breakthrough medicines of tomorrow.”

To support the project Eli Lilly will be eligible to receive an Major Employment and Investment (MEI) Project Approval Commission-approved special appropriation of up to $130 million based on an investment of more than $2.148 billion and the creation of 468 jobs, subject to approval by the Virginia General Assembly.

“For nearly 150 years, Eli Lilly and Company has worked to address the medical mysteries others considered impossible. Today, Virginia is joining them on that mission,” noted Secretary of Commerce and Trade Juan Pablo Segura. “With this investment, Lilly isn’t just bringing great jobs and new facilities; they are bringing the promise of a healthier future for all Americans.”

Support for?Lilly’s job creation will be provided through the Virginia Talent Accelerator Program. The program, created by Virginia Economic Development Partnership (VEDP) in collaboration with higher education partners, accelerates new facility startups and expansions through the direct delivery of recruitment and training services that are fully customized to a company’s unique products, processes, equipment, standards and culture. All program services are provided at no cost to qualified new and expanding companies as an incentive for job creation.

“Lilly’s decision to locate its first Virginia biopharmaceutical manufacturing facility in Goochland County is exciting news,” added Dominion Energy Virginia President and Executive Vice President of Utility Operations Edward H. Baine. “Dominion Energy Virginia is honored to partner with Lilly for its long-term success in the region. We look forward to providing the reliable, affordable, increasingly clean energy needed for Lilly to successfully reach new markets and deliver innovative medicines to patients.”

Eli Lilly currently operates U.S. manufacturing facilities in Indiana, North Carolina, New Jersey, Wisconsin, and Puerto Rico.

Exclusive Research